Status:
ACTIVE_NOT_RECRUITING
Prostate Cancer Prospective Cohort
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
Johns Hopkins University
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Eligibility:
MALE
18-100 years
Brief Summary
The overall purpose of this research is to determine if certain genes increase the chance of developing prostate cancer and once diagnosed increase the chance of the prostate cancer spreading to other...
Detailed Description
DNA will be isolated from each person and then studied for the presence of certain genes that may increase the chance of developing prostate cancer. Certain genes will also be studied in patients with...
Eligibility Criteria
Inclusion
- Newly diagnosed patients: 1. newly diagnosis of prostate cancer 2. untreated except for neoadjuvant systemic therapy.
Exclusion
- Newly diagnosed patients: 1. inability to give informed consent
Key Trial Info
Start Date :
May 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2027
Estimated Enrollment :
1937 Patients enrolled
Trial Details
Trial ID
NCT00937586
Start Date
May 1 2000
End Date
June 1 2027
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110